TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
VSTM

Verastem Inc

Healthcare · Biotechnology

7.70$ -0.8% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Verastem Inc (VSTM) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 207 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet VSTM
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
176 150 124 106 126 102 132 196 177 246 228 207
174 144 118 100 121 95 125 174 154 223 203 176
95 78 81 83 113 89 118 164 138 205 166 136
166 137 110 83 113 89 118 164 138 214 182 136
0.0 0.0 0.2 11 0.2 0.2 0.2 2.3 6.7 0.2 10 29
0.0 – – – – 0.0 – 1.2 1.8 1.8 2.3 2.4
– – – – – – – 16 17 16 16 16
72 92 77 66 94 130 164 160 192 189 146 157
24 26 27 30 37 31 36 50 60 72 67 78
1.3 0.9 1.9 6.5 11 1.0 3.0 4.2 5.1 5.8 6.3 6.4
5.1 7.2 7.4 6.7 4.4 4.0 7.2 8.0 9.9 12 9.6 18
40 40 40 35 31 41 73 81 84 81 77 76
104 57 46 40 32 -29 -32 36 -16 57 82 50
-798 -825 -859 -867 -891 -956 -1,008 -1,034 -1,132 -1,165 -1,202 -1,236
27 27 27 27 40 38 54 74 73 83 99 100

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?